Insider Transactions in Q4 2024 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.1%
|
$2,000
$2.18 P/Share
|
|
Dec 31
2024
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.51%
|
$2,000
$2.18 P/Share
|
|
Nov 18
2024
|
David Hollander CMO & Global Therapeutics Lead |
SELL
Open market or private sale
|
Direct |
3,908
-3.59%
|
$15,632
$4.17 P/Share
|